New appointment announced: Brakmann takes on role as managing director at BAH
Dorothee Brakmann, a seasoned pharmaceutical professional with a rich background in healthcare payers, IT companies, and the German pharmaceutical industry, is set to assume the role of Chief Executive Officer (CEO) at the Federal Association of Pharmaceutical Manufacturers (BAH) starting April 1.
Brakmann, who is also an IT specialist and a qualified pharmacist, will be succeeding Hubertus Cranz as the head of the BAH. Her appointment marks a significant move in the leadership of the German pharmaceutical industry.
Brakmann's career in the German pharmaceutical industry spans across various sectors. She has previously served as the Chief Executive Officer (Hauptgeschäftsführerin) of Pharma Deutschland, the association representing pharmaceutical manufacturers in Germany. Before that, she held a position at Janssen Cilag, where she was responsible for the commercial oncology/haematology area.
Brakmann's tenure at Janssen Cilag was marked by her leadership and contributions, which have been instrumental in driving the company's growth and success. Prior to her tenure at Janssen Cilag, Brakmann gained experience in the IT sector and healthcare payers.
Brakmann holds a Master's degree in Health Business Administration and Medical Management, further equipping her with the necessary skills to lead the BAH effectively. She has been a member of the BAH board since 2019, providing her with a deep understanding of the organization and its operations.
Hubertus Cranz, who is stepping down as CEO, has led the BAH with distinction and will be leaving big shoes to fill. The BAH board and the entire German pharmaceutical industry wish him all the best in his future endeavors.
As Brakmann prepares to take the helm, the BAH and the German pharmaceutical industry look forward to the fresh perspectives and leadership she will bring to the table. Her extensive experience and qualifications make her well-equipped to navigate the challenges and opportunities that lie ahead in the German pharmaceutical industry.
Read also:
- Mobile Health Teams Patrolling Almaty City: Operations in the Metropolis
- Prepare for August and September events or activities
- Unexplored Tropical Fruits: Investigating their Impact on Cognitive Longevity and Health Benefits
- Transforming Spaces for Fresh Air: The Role of Architecture and Interior Design in Promoting Healthier Environments
